TransMedics Group Inc (TMDX)

Operating return on assets (Operating ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 37,496 31,455 -803 -14,217 -28,727 -38,109 -15,318 -24,157 -31,437 -35,986 -42,167 -42,290 -39,428 -33,996 -26,881 -24,874 -26,384 -29,182 -31,814 -31,658
Total assets US$ in thousands 804,076 785,571 758,577 723,831 706,047 689,227 690,358 287,088 277,147 274,873 117,285 124,008 134,893 131,146 140,512 145,783 152,026 159,322 163,137 96,923
Operating ROA 4.66% 4.00% -0.11% -1.96% -4.07% -5.53% -2.22% -8.41% -11.34% -13.09% -35.95% -34.10% -29.23% -25.92% -19.13% -17.06% -17.35% -18.32% -19.50% -32.66%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $37,496K ÷ $804,076K
= 4.66%

TransMedics Group Inc's operating return on assets (operating ROA) experienced a declining trend from March 31, 2020, to June 30, 2022, with negative percentages ranging from -32.66% to -35.95%. This suggests that during this period, the company may have struggled to generate profits from its operating activities in relation to its asset base.

However, starting from September 30, 2022, there was a notable improvement in the operating ROA, with the percentage increasing to 4.00% by September 30, 2024, and further improving to 4.66% by December 31, 2024. This turnaround indicates that TransMedics Group Inc's operational efficiency and profitability improved during this time frame, potentially through better utilization of its assets or cost management.

Overall, the positive trend in operating ROA from September 30, 2022, to December 31, 2024, reflects a more favorable performance in terms of generating returns from its operating activities relative to its asset base, signaling potential operational improvements and enhanced financial health for the company.